• Contact
  • Login
  • Contact
  • Login
  • TTM2

  • Menu
  • Contact
  • Login
  • About the study
    • History
    • Who are we
  • News
  • Documents
  • Sites
  • Partners
  • Substudies

TTM2-trial soon to start

10 November 2017

After almost one year of planning we are delighted to announce that the TTM2-trial is soon ready to start in a selected group of vanguard sites. These sites will get the oportunity to give constructive feed back on instructions, trial infrastructure and protcol and will therefore pave the way for the main body of trial sites that will be initiated and start recruiting with the next quarter. Co-enrolment with the TAME-trial, additions of exiting and important sub-studies,  and the start up of a large biobank at the Integrated Biobank of Luxembourg will be inspiring projects within the TTM2-trial. Please take the oportunity to find additional trial material at this home page and look out for the news that the trial is launched.

News

Past 500

15 January 2019

Newsletter Dec - 12

12 December 2018

Screening Log

12 December 2018

Inclusion update (Nov 19) - 332 participants

19 November 2018

Neurofilament article in JAMA Neurology

30 October 2018

Inclusion update (Oct 25) - 267 participants,

25 October 2018

Neuroprognostication videos

17 September 2018

Site inclusion update

04 September 2018

August Update - 192 participants

29 August 2018

eCRF going live and some temporary procedures.

04 May 2018

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

Helsingborg Hospital 
Anaesthesiology and Intensive Care 
Charlotte Yhlens gata 10
251 87 Helsingborg, Sweden
ttm2@ttm2trial.org

Skåne University Hospital
Center for Cardiac Arrest
Barngatan 2A, Practicum
22185 Lund, Sweden
ttm2@ttm2trial.org